Evidence map›Paper›PMID 30324146›Full record

ArticleClinical and experimental hepatology2018

Cellulitis in liver cirrhosis - a series of 25 cases from southern India.

Uday Sanglodkar, Mayank Jain, Dinesh Jothimoni, Subhashree Parida, Balajee G, Jayanthi Venkataraman

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Clinical and experimental hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Unilateral Pseudo-Ainhum in Liver Cirrhosis.Open access Macedonian journal of medical sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Uday SanglodkarLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.
Mayank JainLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.
Dinesh JothimoniLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.
Subhashree ParidaLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.
Balajee GLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.
Jayanthi VenkataramanLiver and Gastroenterology Units, Gleneagles Global Health City, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCirrhosis of the liver predisposes patients to serious bacterial infections including cellulitis. The aim of the study was to determine the clinical and bacteriological profile of cellulitis in patients with liver cirrhosis. MATERIAL AND

methodsIn this prospective study, consecutive cirrhotic patients hospitalized between February and September 2017 were enrolled. Data retrieved included demographics, aetiology, co-morbidity, cirrhosis-related complications, site of cellulitis, baseline investigations, and wound and blood culture.

resultsThree hundred and thirty-eight patients were admitted, of whom 25 had cellulitis (mean age 52.8 ± 10.4 years, men 88.0%, median MELD [model of end-stage liver disease] 18.8 ± 10.4). Non-alcoholic steatohepatitis and alcohol were each the cause of cirrhosis in 40% of cases. Nine patients (36%) had diabetes mellitus. Cultures were positive in 13 cases (52%; 1 - blood, 11 - wound, 1 - both blood and skin). The majority of the cultures showed monomicrobial growth (9; 70%).

conclusionsPrevalence of cellulitis was 7.4% in hospitalised cirrhotics. Culture positivity was 52%.

Indexed as

alcoholismchronic liver diseaseinfection

Identifiers

PMID30324146
PMCPMC6185931
OpenAlexW2896335264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.